Kalehua Capital Management »

Tscan Therapeutics shares owned by Kalehua Capital Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Kalehua Capital Management from 13F filings

Historical chart of Kalehua Capital Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Kalehua Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $446k 455k 0.98

More positions owned by Kalehua Capital Management

Ea Series Trust Alpha Arch 1-3 (BOXX)
Veradermics Common Stock (MANE)
Veradermics Coomon Stock (MANE)
X4 Pharmaceuticals Com New (XFOR)
X4 Pharmaceuticals Com New (XFOR)
Compass Pathways Sponsored Ads (CMPS)
Compass Pathways Sponsored Ads (CMPS)
Surrozen Com New (SRZN)
Surrozen Com New (SRZN)
Aclaris Therapeutics (ACRS)
Aclaris Therapeutics (ACRS)
Sionna Therapeutics (SION)
Sionna Therapeutics (SION)
Inhibikase Therapeutics Com New (IKT)
Inhibikase Therapeutics Com New (IKT)

View all positions for Kalehua Capital Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
Vanguard Capital Management
Two Sigma Investments
Renaissance Technologies
Acadian Asset Management
Deer Management
Millennium Management
Jacobs Levy Equity Management
Citadel Advisors
BlackRock
Boothbay Fund Management
Marshall Wace
DC Funds

View all funds holding Tscan Therapeutics